More News

27 Sep 2018 Cellular Biomedicine Group Enters Into Strategic Licensing and Collaboration Agreement with a Global Leader in CAR-T Cell Therapy for Patients in China
27 Sep 2018 Chugai and Lilly Enter into a License Agreement for Oral GLP-1 Agonist, OWL833
26 Sep 2018 Alexion to Acquire Syntimmune
26 Sep 2018 Cerecor to Acquire Ichorion Therapeutics
24 Sep 2018 Lumos Pharma Acquires Candidate for Oral Treatment of Growth Hormone Deficiency
21 Sep 2018 Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders
19 Sep 2018 Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy
19 Sep 2018 Integral Molecular Partners with Merus to Discover Novel Therapeutic Monoclonal Antibodies
18 Sep 2018 Novo Nordisk announces plans to transform its approach to Research & Development
18 Sep 2018 Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
18 Sep 2018 MorphoSys and LEO Pharma Expand Strategic Alliance to Develop Peptide-derived Therapeutics
17 Sep 2018 ITM and Merck KGaA Sign Research Evaluation and Option Agreement to Develop Folate Receptor Targeted Radionuclide Therapy
17 Sep 2018 CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes
15 Sep 2018 Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
14 Sep 2018 Supernus to Acquire Biscayne Neurotherapeutics
13 Sep 2018 Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
13 Sep 2018 VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals for As-Needed Treatment of Social Anxiety Disorder
13 Sep 2018 Gilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing
10 Sep 2018 CCAB and Triumvira Immunologics Announce Triumvira’s License Agreement with University of Toronto for the Discovery of Antibody Drug Development Candidates
08 Sep 2018 CYTOO enters into Research and Option Agreement with Pfizer to develop a target discovery platform for Duchenne Muscular Dystrophy
07 Sep 2018 Zealand sells royalty streams and milestones for USD 205 million to Royalty Pharma
06 Sep 2018 Atara Biotherapeutics and Moffitt Cancer Center Announce Strategic Collaboration to Develop Next-Generation CAR T Immunotherapies
05 Sep 2018 Biohaven Licenses Novel Myeloperoxidase Inhibitor From AstraZeneca: Potential First-In-Class Treatment For Multiple System Atrophy
04 Sep 2018 Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
04 Sep 2018 Turnstone Biologics and the La Jolla Institute for Allergy and Immunology Enter into Strategic Collaboration for Personalized Neoantigen Immunotherapies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up